According to Roth (1964), the term "psychopharmakon" was used for the first time by Reinhardus Lorichius of Hadamar who, in 1548, edited a collection of prayers of comfort and in preparation for death under the title "Psychopharmakon, hoc est: medicina animae". With the introduction of chlorpromazine in 1952, the era of psychopharma cology began. The "psychopharmakon" of the Renaissance and the twentieth century differ from each other in concept and meaning; the spiritual support in times of increased anxiety and fear has been replaced by drugs which "tranquilize" the agitated and brighten the mood of the depressed. Thus, the pioneering discovery by Delay et al. (1952) of the usefulness of phenothiazines in schizophrenics, followed by the report of Loomer et al. (1957) on the antidepressant effect of iproniazid and Kuhn's (1957) observation of the thymoleptic property of imipramine triggered a revolution in psychiatry. Subsequently, numerous new psychopharmaka have been introduced. Parallel with this development, the interest in experimental behavioral research which began to utilize the newly discovered drugs as tools grew rapidly. The experience gained from studies of human and animal behavior found expression in the attempt to introduce a nomenclature and classify psychopharmaka on a purely psychological basis.
According to Roth (1964), the term "psychopharmakon" was used for the first time by Reinhardus Lorichius of Hadamar who, in 1548, edited a collection of prayers of comfort and in preparation for death under the title "Psychopharmakon, hoc est: medicina animae". With the introduction of chlorpromazine in 1952, the era of psychopharma cology began. The "psychopharmakon" of the Renaissance and the twentieth century differ from each other in concept and meaning; the spiritual support in times of increased anxiety and fear has been replaced by drugs which "tranquilize" the agitated and brighten the mood of the depressed. Thus, the pioneering discovery by Delay et al. (1952) of the usefulness of phenothiazines in schizophrenics, followed by the report of Loomer et al. (1957) on the antidepressant effect of iproniazid and Kuhn's (1957) observation of the thymoleptic property of imipramine triggered a revolution in psychiatry. Subsequently, numerous new psychopharmaka have been introduced. Parallel with this development, the interest in experimental behavioral research which began to utilize the newly discovered drugs as tools grew rapidly. The experience gained from studies of human and animal behavior found expression in the attempt to introduce a nomenclature and classify psychopharmaka on a purely psychological basis.
You May Like
Customers Also Viewed
Discover your next great read at BookLoop, Australia's trusted online bookstore offering a vast selection of titles across various genres and interests. Whether you're curious about what's trending or searching for graphic novels that captivate, thrilling crime and mystery fiction, or exhilarating action and adventure stories, our curated collections have something for every reader. Delve into imaginative fantasy worlds or explore the realms of science fiction that challenge the boundaries of reality.
Stay updated with the literary world by browsing our trending books, featuring the latest bestsellers and critically acclaimed works. Explore titles from popular brands like Minecraft, Pokemon, Star Wars, Bluey, Lonely Planet, ABIA award winners, Peppa Pig, and our specialized collection of ADHD books. At BookLoop, we are committed to providing a diverse and enriching reading experience for all.
Sign In
your cart
Your cart is empty
Menu
Search
PRE-SALES
If you have any questions before making a purchase chat with our online operators to get more information.
